Supporting Biotech Research through Preclinical Services
In the realm of biotechnology, where groundbreaking discoveries pave the way for new therapies, biotech companies have one objective: bring new biotechnologies to market. For that, collaborate with CROs is crucial to access to expertise, resources, and a strategic approach until the IND-enabling. As time is a critical factor in the pharmaceutical industry, CRO capabilities proven processes that accelerate development, shortening the time needed to bring innovative therapies to market.
This article delves into the pivotal role of preclinical services in supporting biotech research and accelerating the development of life-changing therapies.
Understanding Preclinical Services: a foundation for Biotechnology innovation
Preclinical services encompass a range of scientific activities conducted before human clinical trials, aimed at evaluating the safety and efficacy of potential therapeutics. From pharmacology and toxicology studies to ADME (absorption, distribution, metabolism, and excretion) assessments, these services provide crucial insights into the viability of new drug candidates.
Preclinical Solutions for Biotech Success with Oncodesign Services
As a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services, we understand the unique needs of biotech companies embarking on the journey of therapy development. Whether exploring novel targets, expanding therapeutic indications, or optimizing drug formulations, our comprehensive suite of preclinical services equips biotech companies with the tools they need to unlock their full potential. From early-stage discovery to late-stage development, we stand as a trusted partner in the journey towards therapeutic breakthroughs.
Our tailored and integrated solutions offer comprehensive support across all stages of preclinical research, empowering biotech innovators to advance their pipeline with confidence.
- Identification of promising drug candidate with cutting-edge techniques such as high-throughput screening, in silico modeling, biophysical assays
- Lead optimization and proof of concept with experimented preclinical services
- In vitro Biology
- DMPK/ADME
- Bioanalysis
- In vivo pharmacology
- Imaging modalities
To navigate regulatory hurdles and to ensure compliance and safety of new technologies, our regulatory affairs experts collaborate closely with biotech partners, from study design to dossier preparation.
A Partnership for Progress and Innovation
At Oncodesign Services, we believe in the power of collaboration to drive meaningful progress in biotech research. By fostering open communication and transparent collaboration, we cultivate strong partnerships with our biotech clients. Together, we share a common goal: to translate innovative ideas into tangible therapies that improve patient outcomes and transform lives.
We are committed to empowering biotech innovators with the expertise, technology, and support they need to bring their vision to fruition. Together, we will continue to push the boundaries of science and shape the future of healthcare. Join us in our mission to accelerate discovery, advance therapies, and transform lives!
Ready to embark on your journey towards therapeutic discovery? Contact us today to learn more about our comprehensive suite of preclinical services and how we can support your biotech research initiatives.
